Alussa Energy Acquisition Corp II Class A ALUB
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $10.13
- Day Range
- $10.14–10.18
- 52-Week Range
- $0.00–10.18
- Bid/Ask
- $4.06 / $10.37
- Shares Outstanding
- 35.94M
- Market Cap
- $364.41M
- Volume/Avg
- 2,737 / 56,754
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Alussa Energy Acquisition Corp II is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.
- Sector
- Financial Services
- Industry
- Shell Companies
- Stock Style Box
- —
- Total Number of Employees
- 0
- Website
- https://www.alussaenergy.com
Valuation
|
Metric
|
ALUB
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.32 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
ALUB
|
|---|---|
Quick Ratio | 1.67 |
Current Ratio | 1.98 |
Interest Coverage | — |
Quick Ratio
ALUB
Profitability
|
Metric
|
ALUB
|
|---|---|
Return on Assets (Normalized) | −1.67% |
Return on Equity (Normalized) | −1.79% |
Return on Invested Capital (Normalized) | −1.79% |
Return on Assets
ALUB
Shell Companies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vylor Inc
VYLR
| LOCK|<V#$>w$ | LOCK|xy# | $51B | |||
| Drugs Made In America Acquisition II Corp
DMII
| — | LOCK|<!$@ | $649M | |||
| Churchill Capital Corp XI Common shares class A
CCXI
| — | LOCK|sSz | $621M | |||
| EQV Ventures Acquisition Corp II Class A
EVAC
| — | LOCK|y@Z&& | $603M | |||
| Bain Capital GSS Investment Corp Class A
BCSS
| — | LOCK|V>>R | $598M | |||
| Cantor Equity Partners IV Inc Ordinary Shares - Class A
CEPF
| — | LOCK|F!!! | $588M | |||
| Churchill Capital Corp XII Class A
CXII
| — | LOCK|p$r | $581M | |||
| American Exceptionalism Acquisition Corp A Ordinary Shares-Class A
AEXA
| — | LOCK|#>#Yx | $539M | |||
| New America Acquisition I Corp Class A
NWAX
| — | LOCK|Mt>@ | $501M | |||
| Ares Acquisition Corp III Class A
AAC
| — | LOCK|VbF>t | $495M |
United States